

HY-P99489 · 1 mg
MedChemExpress · Cat: HY-P99489
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/budigalimab.html
Description
Budigalimab ABBV 181; PR 1648817 is a humanized, recombinant IgG1 monoclonal antibody targeting programmed cell death 1 PD-1 receptor. Budigalimab has an Fc mutation that reduces the inhibition of Fc receptor interactions and effector factors. Budigalimab can block the binding of PD-1 and PD-L1, which has anti-tumor activity. Budigalimab can be used in the study of solid tumors.